AUTHOR=Chen Min , Gao Kai , Ali Kamran , Shan Jinpeng , Qiu YunMi , Xie Tianci , Yu Yiling , Wu Liming 

TITLE=Case report: Dupilumab leads to an increased chance of head and neck Staphylococcus aureus infection in atopic dermatitis patients

JOURNAL=Frontiers in Medicine

VOLUME=10

YEAR=2023

URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1027589

DOI=10.3389/fmed.2023.1027589

ISSN=2296-858X

ABSTRACT=<p>Dupilumab was the first biological medication licensed to treat atopic dermatitis (AD), and it has shown remarkable effectiveness and safety in the treatment of moderate-to-severe atopic dermatitis. There are limited drug-related adverse events associated with dupilumab in atopic dermatitis (AD) treatment. Here, we present two cases of local <italic>Staphylococcus aureus</italic> infection during the treatment of atopic dermatitis with dupilumab.</p>